AA
SRNE

Ancora Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Ancora Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed – – 2600
2025
Q4 		$0 Buy
+5
New – ﹤0.01% 2545

Other funds holding SRNE

VWA
VSM Wealth Advisory Hunt Valley, Maryland $376M AUM 21.56% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
OC
Oakworth Capital Birmingham, Alabama $2.1B AUM 24.07% 1-Year Est. Return

Ancora Advisors's SRNE Position: Q1 2026 in Review

Ancora Advisors sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2026, closing a stake of 5 shares.

Ancora Advisors first reported a position in SRNE in Q4 2025 and held it in 1 quarter. The position peaked at $0 in Q4 2025. 4 funds tracked by Wall St. Rank hold SRNE as of Q1 2026.

  • Ancora Advisors reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2026 after selling out during the quarter.
  • Ancora Advisors sold 5 Sorrento Therapeutics, Inc. shares in Q1 2026.
  • Ancora Advisors first reported a position in Sorrento Therapeutics, Inc. in Q4 2025 and held it in 1 quarter.
  • Ancora Advisors's Sorrento Therapeutics, Inc. position peaked at $0 in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.